The factor VII zymogen structure reveals reregistration of beta strands during activation.Eigenbrot, C., Kirchhofer, D., Dennis, M.S., Santell, L., Lazarus, R.A., Stamos, J., Ultsch, M.H.
(2001) Structure 9: 627-636
- PubMed: 11470437
- PubMed Abstract:
- Peptide Exosite Inhibitors of Factor VIIa as Anticoagulants
Dennis, M.S.,Eigenbrot, C.,Skelton, N.J.,Ultsch, M.H.,Santell, L.,Dwyer, M.A.,O'Connell, M.P.,Lazarus, R.A.
(2000) Nature 404: 465
- Structure of Extracellular Tissue Factor Complexed with Factor VIIa Inhibited with a BPTI Mutant
Zhang, E.,St.Charles, R.,Tulinsky, A.
(1999) J.Mol.Biol. 285: 2089
- Crystal Structure of Active Site-inhibited Human Coagulation Factor VIIa (des-Gla)
Kemball-Cook, G.,Johnson, D.J.,Tuddenham, E.G.,Harlos, K.
(1999) J.STRUCT.BIOL. 127: 213
- Structure of Human Factor VIIa and its Implications for the Triggering of Blood Coagulation
Pike, A.C.,Brzozowski, A.M.,Roberts, S.M.,Olsen, O.H.,Persson, E.
(1999) Proc.Natl.Acad.Sci.USA 96: 8925
- The Crystal Structure of the Complex of Blood Coagulation Factor VIIa with Soluble Tissue Factor
Banner, D.W.,D'Arcy, A.,Chene, C.,Winkler, F.K.,Guha, A.,Konigsberg, W.H.,Nemerson, Y.,Kirchhofer, D.
(1996) Nature 380: 41
- A Novel Exosite on Coagulation Factor VIIa and its Molecular Interactions with a New Class of Peptide Inhibitors
Roberge, M.,Santell, L.,Dennis, M.S.,Eigenbrot, C.,Dwyer, M.A.,Lazarus, R.A.
() TO BE PUBLISHED --: --
Coagulation factor VIIa (FVIIa) contains a Trypsin-like serine protease domain and initiates the cascade of proteolytic events leading to Thrombin activation and blood clot formation. Vascular injury allows formation of the complex between circulatin ...
Coagulation factor VIIa (FVIIa) contains a Trypsin-like serine protease domain and initiates the cascade of proteolytic events leading to Thrombin activation and blood clot formation. Vascular injury allows formation of the complex between circulating FVIIa and its cell surface bound obligate cofactor, Tissue Factor (TF). Circulating FVIIa is nominally activated but retains zymogen-like character and requires TF in order to complete the zymogen-to-enzyme transition. The manner in which TF exerts this effect is unclear. The structure of TF/FVIIa is known. Knowledge of the zymogen structure is helpful for understanding the activation transition in this system.
Department of Protein Engineering and, Genentech, Inc., South, San Francisco, CA, USA. email@example.com